Top Markets
Coin of the day
BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

BBOT
Ранг среди акций #11443
BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical... BridgeBio Oncology Therapeutics functions as a clinical-stage biopharmaceutical firm dedicated to pioneering advanced small molecule treatments. These therapies are aimed at combating malignancies driven by RAS and PI3Kα, both frequently encountered oncogenes in human cancers. Initially established as an offshoot of BridgeBio Pharma, the company concentrates on precision oncology. Its developmental pipeline features several promising programs, including BBO-8520, BBO-10203, and BBO-11818, all specifically designed to modulate the KRAS and PI3K pathways. The company recently became publicly traded through a business combination with Helix Acquisition Corp. II. This strategic move successfully raised approximately $450 million, which will be utilized to further its clinical development initiatives. The leadership team comprises Dr. Eli Wallace as Chief Executive Officer and Dr. Pedro Beltran as Chief Scientific Officer.
Цена акции
$8.74
Последняя синхронизация: 2026-08-28
Рыночная капитализация
$699.74M
Изменение (1 день)
-4.85%
Изменение (1 год)
-2.29%
Страна
US
Торговля BridgeBio Oncology Therapeutics Inc. (BBOT)

Категория

История дроблений акций BridgeBio Oncology Therapeutics Inc. (BBOT)
Акции BridgeBio Oncology Therapeutics Inc. (символ: BBOT) прошли через 0 дроблений.
Последнее дробление произошло Aug 30, 2026.
Одна акция BBOT, купленная до Aug 30, 2026, сейчас соответствует 0 акциям BBOT.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH